Topic Review
Alternative Splicing in Immunomodulatory Genes
The interaction between the tumor and immune cells within the tumor microenvironment is facilitated by signaling pathways driven by immunomodulatory proteins. Alternative splicing regulates the production of multiple immunomodulatory proteins with diverse functionality from a single mRNA transcript. Splicing factors are pivotal in modulating alternative splicing processes but are also subject to regulation. The dysregulation of alternative splicing may result from splicing factor (SF) abnormal expression levels and mutations in the cis and trans-acting elements and small nuclear RNA (snRNA) molecules. Aberrant splicing may generate abnormal mRNA transcripts encoding isoforms with altered functions that contribute to tumorigenesis or cancer progression.
  • 234
  • 30 Aug 2023
Topic Review
Alveolar Macrophages
At the early stages of life development, alveoli are colonized by embryonic macrophages, which become resident alveolar macrophages (ResAM) and self-sustain by local division. Genetic and epigenetic signatures and, to some extent, the functions of ResAM are dictated by the lung microenvironment, which uses cytokines, ligand-receptor interactions, and stroma cells to orchestrate lung homeostasis. 
  • 607
  • 05 Nov 2021
Topic Review
Amygdala Neuroinflammation and Psychiatric Disorders
Depression and anxiety disorder are the most common mental diseases affecting hundreds of millions of people worldwide. The comorbidity rate of anxiety disorder and depression is very high, with 74% of depressed patients having anxiety symptoms, while 61% of anxious patients have depression symptoms. Stress exposure is widely accepted as a critical contributing factor to psychological and neuropathological disorders. Especially during the COVID-19 pandemic, the high pressure of increasingly demanding work and life has led to a sharp rise in the incidence of mental diseases. Inflammation induces psychological and neuropathological disorders by influencing neuronal excitability, neurotransmitter release, receptor, and transporter expression through peripheral hormones and autonomic responses. A number of animal and human studies have revealed that the amygdala, ventral hippocampus, and medial prefrontal cortex (mPFC) are extensively involved in the occurrence of anxiety, depression, and related behavioral regulation. Among them, the amygdala, one of the kernel brain regions mediating stress-coping located in the deep temporal lobe, is considered the hub center for processing emotionally salient stimuli and implementing appropriate behavioral responses.
  • 720
  • 23 Feb 2023
Topic Review
Anakinra Therapy for Deficiency of Interleukin-1 Receptor Antagonist
Deficiency of interleukin-1 receptor antagonist (DIRA) is a rare life-threatening autosomal recessive autoinflammatory disease with symptoms including but not limited to osteomyelitis, periostitis, and systemic inflammation. DIRA is developed from the loss-of-function biallelic mutations of the IL1RN gene that encodes IL-1 receptor antagonist (IL-1RA), leading to the unchecked pro-inflammatory signaling and subsequent systemic inflammation. 
  • 74
  • 01 Mar 2024
Topic Review
Animal Inflammatory Bowel Disease
In the development of inflammatory bowel disease (IBD), the gut microbiota has been established as a key factor. Recently, metabolomics has become important for understanding the functional relevance of gut microbial changes in disease. Animal models for IBD enable the study of factors involved in disease development. However, results from animal studies may not represent the human situation. The aim of this study was to investigate whether results from metabolomics studies on animal models for IBD were similar to those from studies on IBD patients. Medline and Embase were searched for relevant studies up to May 2017. The Covidence systematic review software was used for study screening, and quality assessment was conducted for all included studies. Data showed a convergence of ~17% for metabolites differentiated between IBD and controls in human and animal studies with amino acids being the most differentiated metabolite subclass. The acute dextran sodium sulfate model appeared as a good model for analysis of systemic metabolites in IBD, but analytical platform, age, and biological sample type did not show clear correlations with any significant metabolites. In conclusion, this systematic review highlights the variation in metabolomics results, and emphasizes the importance of expanding the applied detection methods to ensure greater coverage and convergence between the various different patient phenotypes and animal models of inflammatory bowel disease.
  • 594
  • 27 Oct 2020
Topic Review
Animal Models of Neutropenia
Animal models of neutropenia are indispensable tools in biomedical research, offering unique insights into the causes, mechanisms, and potential treatments for this hematologic disorder. Neutropenia, characterized by a decreased number of neutrophils in the blood, can result from diverse factors, including chemotherapy, genetic mutations, autoimmune processes, and infections. Understanding these varied etiologies necessitates the use of different animal models, each tailored to specific research goals. Chemotherapy-induced neutropenia is a critical concern in cancer treatment, and mouse and rat models provide valuable platforms for studying drug-induced hematopoietic toxicity. These models enable precise control over drug exposure and dose, facilitating the development of supportive therapies. Genetic neutropenias, often associated with specific mutations, are investigated using murine and zebrafish models. These models allow researchers to replicate genetic conditions and explore potential therapeutic targets. Immune-mediated neutropenias, characterized by autoimmune responses against neutrophils, are studied in mice and non-human primates, providing insights into the immunopathological mechanisms involved and the testing of immunosuppressive interventions. Infection-induced neutropenia models, employing mice, zebrafish, and fruit flies, help elucidate host-pathogen interactions and the impact of infections on neutrophil production. By harnessing the strengths of these diverse animal models, scientists can deepen their understanding of neutropenia, advancing diagnostics and treatments for this clinically significant condition.
  • 207
  • 11 Oct 2023
Topic Review
Annelid Immune Response to Nanoparticles
Earthworms and leeches are sentinel animals that represent the annelid phylum within terrestrial and freshwater ecosystems, respectively. One early stress signal in these organisms is related to innate immunity, but how nanomaterials affect it is poorly characterized. In this survey, we compare the latest literature on earthworm and leeches with examples of their molecular/cellular responses to inorganic (silver nanoparticles) and organic (carbon nanotubes) nanomaterials. A special focus is placed on the role of annelid immunocytes in the evolutionarily conserved antioxidant and immune mechanisms and protein corona formation and probable endocytosis pathways involved in nanomaterial uptake. Our summary helps to realize why these environmental sentinels are beneficial to study the potential detrimental effects of nanomaterials.
  • 626
  • 07 Dec 2020
Topic Review
Anti-Cancer Effects of Atrial Natriuretic Peptides
The atrial natriuretic peptide (ANP), a cardiovascular hormone, plays a pivotal role in the homeostatic control of blood pressure, electrolytes, and water balance and is approved to treat congestive heart failure. In addition, there is a growing realization that ANPs might be related to immune response and tumor growth. The anti-inflammatory and immune-modulatory effects of ANPs in the tissue microenvironment are mediated through autocrine or paracrine mechanisms, which further suppress tumorigenesis. In cancers, ANPs show anti-proliferative effects through several molecular pathways. Furthermore, ANPs attenuate the side effects of cancer therapy. Therefore, ANPs act on several hallmarks of cancer, such as inflammation, angiogenesis, sustained tumor growth, and metastasis. 
  • 572
  • 12 Oct 2022
Topic Review
Anti-DNA Antibodies in Systemic Lupus Erythematosus
Anti-DNA antibodies are hallmark autoantibodies produced in systemic lupus erythematosus (SLE), but their pathogenetic role is not fully understood. Accumulating evidence suggests that some anti-DNA antibodies enter different types of live cells and affect the pathophysiology of SLE by stimulating or impairing these cells.
  • 154
  • 27 Nov 2023
Topic Review
Anti-Ro Antibodies and fetal complications
Maternal anti-Ro antibodies present during the fetal period can cause complications ranging from congenital heart block, fetal demise or long-term consequences. The anti-Ro induced autoimmune reaction causes long-term fibrosis and calcification of the conductive tissue. In addition, the CHB injury mechanisms were shown to involve other factors, like fetal susceptibility that increases for every subsequent pregnancy, from a 2% incidence in the case of nulliparous mothers. The predictive value of maternal anti-Ro antibodies for CHB high-risk pregnancy is low, and other markers are lacking, making this condition difficult to efficiently monitor. Moreover, the positive anti-Ro pregnancies do not benefit from a prophylactic treatment or from an efficient therapy once CHB was diagnosed. Thus, new data from ongoing trials are highly expected, to provide both potential biomarkers and therapeutic solutions. This entry illustrates the current understanding of the anti-Ro antibodies associated pathologies, from the perspective of specialists involved in its management, emphasizing key issues, missing links, and possible future directions for an effective interdisciplinary approach.
  • 1.9K
  • 08 Nov 2020
  • Page
  • of
  • 78